Keros Therapeutics Inc. (KROS)
NASDAQ · Healthcare
Keros Therapeutics Inc. Cash Flow 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Operating Cash Flow | 107.5M | -160.9M | -124.5M | -70.1M | -62.1M | -36.9M | -16.0M |
| Depreciation & Amort. | — | — | — | — | — | — | — |
| Investing Activities | |||||||
| Capital Expenditure | 1.6M | 1.9M | 2.5M | 1.2M | 1.0M | 294,000 | 271,000 |
| Free Cash Flow | 106.0M | -162.8M | -127.0M | -71.3M | -63.2M | -37.2M | -16.3M |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Buybacks | 375.0M | 0 | — | — | — | — | — |
Keros Therapeutics Inc. Cash Flow — FAQ
Keros Therapeutics Inc. (KROS) cash flow over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see KROS's cash flow history?
The chart and table above show Keros Therapeutics Inc.'s cash flow by year and by quarter, including the growth rate.